Burst vs. Tonic Dorsal Root Ganglion Stimulation Trial

Burst vs. Tonic Dorsal Root Ganglion Stimulation Trial - Burst DRG

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028277

Enrollment

Registered

2022-02-28

Start date

2022-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.1

Interventions

Group 1: Tonic stimulation - external tonic stimulation for 7 days Group 2: Burst stimulation - external burst stimulation for 7 days

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Implantation of a test lead for dorsal root ganglion stimulation trial. 2. Pain intensity of more than 5 on visual analog scale for more than 3 months. 3. The patient has the ability to read, understand and give information reliably as required by the protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with another pain disorder, which could influence the study results 2. Adults unable to give consent 3. Children and adolescents

Design outcomes

Primary

Measure	Time frame
Pain intensity using the visual analog scale (VAS) at the end of the trial phases of tonic and burst stimulation	—

Secondary

Measure	Time frame
Life quality, analgesics intake, patient satisfaction	—

Countries

Germany

Contacts

Public ContactGuilherme Santos Piedade

Universitätsklinikum Düsseldorf

guilherme.santospiedade@med.uni-duesseldorf.de0211 81 16058

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026